ClinicalTrials.Veeva

Menu

Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach (PRECILITH)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Kidney Stone
Nephrolithiasis

Treatments

Biological: Blood and urine samples

Study type

Interventional

Funder types

Other

Identifiers

NCT05237063
PI2021_843_0137

Details and patient eligibility

About

Nephrolithiasis is a disease caused by the formation of kidney stones in the urinary tract which can then partially or completely obstruct the latter causing an extremely sharp pain called renal colic. In industrialized countries, it affects 10 to 20% of the population, and is the most common kidney disease.The primary objective of this study is to identify the clinical, biological, genetic, molecular and environmental determinants predictive of recurrence of renal lithiasis.

The study follow-up visit schedule corresponds to the visits usually scheduled as part of patient care: 1 year from the inclusion visit (A1), 3 years (A3) then 5 years (A5). Samples for research (additional volume of blood, urine) will be taken by a registered nurse along with the routine check-up samples.Samples intended for research will be sent by staff to the Biobanque de Picardie (CHU Amiens-Picardie) for processing and conservation.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (≥18 years old), male or female ,
  • Persons able to understand and object to the information provided (at the discretion of the investigator)
  • Patient affiliated to social security
  • Patient agreeing to sign the informed consent form
  • patient having presented at least one renal colic attack before inclusion

Exclusion criteria

  • Pregnant or breastfeeding woman.
  • Persons deprived of liberty,
  • Adults under legal protection guardianship, or curators or unable to express their consent.
  • Patient refusing to participate in the study
  • Patient in an emergency situation

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Dominique Eladari, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems